Simplifying the Path to Patient-Centric Drug Delivery

As biologics and other complex therapies increasingly move toward self-administration, drug-device combination products require coordinated expertise across development and commercialization. In this presentation, Justin Schroeder, Global Vice President, Technical Sales, discusses the considerations involved in developing combination products, from sterile fill-finish and delivery device selection through packaging and commercial supply. Watch to learn how an integrated development strategy can help simplify complex programmes and support patient-centric drug delivery. #DrugDeviceCombinationProducts #CDMO #DrugDevelopment #LetsTalkFuture